Outsourcing Outlook - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing Outlook

Biopharma Outsourcing Activities Update

April 2, 2014

Pharmaceutical Technology

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Under New Ownership

March 2, 2014

Pharmaceutical Technology

Changes in company ownership shake up the CMO industry.

Novel Expression Systems Opening CMO Opportunities

February 2, 2014

Pharmaceutical Technology

CMOs may find opportunities in alternative expression services.

R&D in Transition

January 2, 2014

Pharmaceutical Technology

The R&D model is in transition and creating new demands on contract services providers.

Climate Change in Outsourcing

December 2, 2013

Pharmaceutical Technology

Ongoing changes create new opportunities for CROs and CMOs.

Disposable Applications in Demand by Biopharma

November 2, 2013

Pharmaceutical Technology

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

The Expense of Vision in Outsourcing

October 2, 2013

Pharmaceutical Technology

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Bioprocessing Advances in Vaccine Manufacture

August 2, 2013

Pharmaceutical Technology

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

What Happened to Outsourcing in Asia?

July 2, 2013

Pharmaceutical Technology

The industry may not be ready for India and China as regulatory issues emerge.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here